Anne M. Horgan - Concepedia

Author

Anne M. Horgan

Also Known As

A Horgan, A M Horgan, A. Horgan, A. M Horgan, A. M. Horgan, A.M. Horgan, A. M. Horgan, Anne Horgan, Anne M Horgan, Anne M. Horgan

139

Publications

Citations

H-Index

Concepts

All Affiliations

Princess Margaret Cancer Centre University Hospital Waterford Toronto General Hospital University Health Network University of Toronto

About

Anne M. Horgan is an author at Princess Margaret Cancer Centre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	513
2	Health Sciences	4	4	86
3	Public Health	1	1	10
4	Family Medicine	1	1	25
5	Gastroenterology	1	1	16

Anne M. Horgan

Publications

999

Citations

H-Index

Page 1

	Year	Citations
Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer Mairéad G. McNamara, Arnoud J. Templeton, Manjula Maganti, European Journal of Cancer Gastrointestinal OncologyMedicineBiliary CancerImmunologyPathology	2014	142
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study Thomas Walter, Anne M. Horgan, Mairéad G. McNamara, European Journal of Cancer Surgical OncologyGastrointestinal OncologyMedicineBiliary CancerLarge Retrospective Study	2012	118
Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology Setting Anne M. Horgan, Natasha B. Leighl, Linda Coate, American Journal of Clinical Oncology	2011	84
Endoscopic or Percutaneous Biliary Drainage for Klatskin Tumors? Thomas Walter, Chia Sing Ho, Anne M. Horgan, Journal of Vascular and Interventional Radiology Biliary CancerBiliary DisorderSurgeryKlatskin Tumors	2012	80
Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial Anne M. Horgan, Boštjan Šeruga, Gregory R. Pond, Journal of Geriatric Oncology UrologyOncologyGenitourinary CancerTax 327Pharmacotherapy	2014	78
A phase II trial of second‐line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma Mairéad G. McNamara, Lisa W. Le, Anne M. Horgan, Cancer	2015	53
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada Benjamin Loveday, Jennifer J. Knox, Laura A. Dawson, Journal of Surgical Oncology	2018	49
Outcome of Adjuvant Therapy in Biliary Tract Cancers Mairéad G. McNamara, Thomas Walter, Anne M. Horgan, American Journal of Clinical Oncology	2013	42
Pharmacogenetic and Germline Prognostic Markers of Lung Cancer Anne M. Horgan, Boming Yang, Abul Kalam Azad, Journal of Thoracic Oncology MedicinePathologyCancer GenomicsBronchial NeoplasmOncology	2011	38
Multicenter, randomized, double‐blind phase 2 trial of <scp>FOLFIRI</scp> with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer Hanna K. Sanoff, Richard M. Goldberg, Anastasia Ivanova, Cancer	2018	36

Page 1